Related references
Note: Only part of the references are listed.Intracellular retention of the NKG2D ligand MHC class I chain-related gene a in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity
Mercedes B. Fuertes et al.
JOURNAL OF IMMUNOLOGY (2008)
Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans
Sabrina Schwartzkopff et al.
JOURNAL OF IMMUNOLOGY (2007)
Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B Ligands of NKG2D
Gopalakrishnan M. Venkataraman et al.
JOURNAL OF IMMUNOLOGY (2007)
Homing and function of human skin γδ T cells and NK cells:: Relevance for tumor surveillance
Lisa M. Ebert et al.
JOURNAL OF IMMUNOLOGY (2006)
IFN-Dependent down-regulation of the NKG2D ligand H60 on tumors
JD Bui et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor
DB Rosen et al.
JOURNAL OF IMMUNOLOGY (2005)
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo
K Wiemann et al.
JOURNAL OF IMMUNOLOGY (2005)
Immune selection of hot-spot β2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy
CC Chang et al.
JOURNAL OF IMMUNOLOGY (2005)
Characterization of human T cells that regulate neutrophilic skin inflammation
P Schaerli et al.
JOURNAL OF IMMUNOLOGY (2004)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein
J Wu et al.
JOURNAL OF IMMUNOLOGY (2003)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
